Bridging Science, Patient Care, and Industry Innovation

Dr. Rickey C. Miller is a distinguished clinical pharmacist, medical science liaison, and healthcare strategist with over 25 years of expertise spanning oncology, hematology, pharmacotherapy, and clinical research. A leader at the intersection of pharmaceutical innovation and patient care, he has dedicated his career to advancing treatment strategies, fostering medical education, and optimizing healthcare outcomes. His global experience across Europe, Asia, and the Americas, combined with a strong foundation in academic leadership and industry collaborations, positions him as a driving force in oncology research and medical affairs.

Currently serving as a medical science liaison at ADMA Biologics, Dr. Miller is instrumental in engaging key opinion leaders (KOLs), leading investigator-initiated research initiatives, and providing scientific insights in hematology, immunology, and transplantation. His expertise in oncology drug development and clinical trial oversight allows him to bridge the gap between translational science and real-world patient care. His ability to analyze emerging scientific trends, communicate complex medical data, and develop strategic medical education programs has made him an invaluable asset in the biopharmaceutical landscape.

Prior to his current role, Dr. Miller served as a clinical pharmacy specialist at WVU Medicine and Allegheny Health Network, where he played a pivotal role in oncology patient management, clinical research, and multidisciplinary team collaboration. He has led efforts in pain management, chemotherapy optimization, and hematology-oncology treatment protocols, ensuring patient safety and quality improvement remain at the forefront of clinical practice.

A passionate educator and mentor, Dr. Miller has held faculty positions at the University of Pittsburgh and Duquesne University, training the next generation of clinical pharmacists and healthcare professionals. His commitment to medical education extends to speaking engagements at global conferences, where he has presented on oncology therapeutics, clinical trial methodologies, and emerging pharmaceutical innovations. As a mentor for the University of Pittsburgh Innovation Institute, he has guided early-stage researchers and healthcare entrepreneurs in bringing their innovations to market.

Dr. Miller’s strategic influence in healthcare consulting is exemplified through Attack the Day, LLC, where he has provided high-level advisory services for pharmacy residency accreditation, electronic health record (EHR) system integration, and clinical program development. His business development acumen and operational expertise have been instrumental in helping healthcare organizations optimize processes and improve patient outcomes.

Throughout his tenure as a medical science liaison at Eli Lilly and Company, Dr. Miller specialized in GU malignancies, engaging with NCI cooperative groups, and leading scientific insight initiatives in oncology. His ability to collaborate with cross-functional teams, integrate data-driven strategies, and drive clinical research advancements has positioned him as a trusted liaison between the pharmaceutical industry and healthcare providers.

Beyond his clinical and industry contributions, Dr. Miller is an active member of several professional organizations, including ASHP, IDSA, ASCO, and ASTCT. His dedication to advocacy, research, and policy development in pharmacy and oncology has made him a respected voice in the field. He has also volunteered extensively, serving as a commission on credentialing member for ASHP and mentoring pharmacy students in clinical skills competitions.

An accomplished researcher and author, Dr. Miller has contributed to peer-reviewed publications, medical textbooks, and scientific conference proceedings. His work in hematology-oncology, pharmacoeconomics, and patient safety research has influenced clinical practice guidelines and oncology treatment pathways. He has also secured and managed research grants ranging from $300,000 to $88 million, driving forward innovative treatment approaches in cancer care.

Outside of his professional achievements, Dr. Miller is a dedicated martial artist with over 30 years of experience in Uechi Ryu Karate, where he serves as a black belt testing committee member and instructor. His personal values of discipline, perseverance, and lifelong learning reflect his commitment to excellence in both his professional and personal pursuits. He is also an avid hockey enthusiast, traveler, and golfer, embracing continuous growth and exploration in all areas of life.

With a Doctor of Pharmacy degree from Duquesne University and specialty residency training at UF Health Jacksonville and H. Lee Moffitt Cancer Center, Dr. Miller has built an unparalleled career in pharmaceutical sciences, oncology, and healthcare leadership. His ability to balance scientific rigor with real-world clinical applications makes him an indispensable leader in advancing medical innovation and patient-centered care.

Character:

Dr. Miller is a dedicated leader and mentor who upholds the highest standards of integrity and professionalism. His adaptability, perseverance, and passion for improving healthcare outcomes define his approach to both clinical practice and industry leadership.

Knowledge:

With extensive expertise in oncology, clinical pharmacology, and medical affairs, Dr. Miller has made significant contributions to pharmaceutical research and patient safety. His deep understanding of drug development, treatment protocols, and healthcare innovations positions him as a valuable resource in advancing medical science.

Strategic:

A visionary problem-solver, Dr. Miller has successfully led clinical research initiatives, business development strategies, and cross-functional collaborations across academia and industry. His ability to analyze complex healthcare challenges and implement impactful solutions has resulted in meaningful advancements in oncology treatment and pharmaceutical innovation.

Communication:

As a skilled educator, public speaker, and medical writer, Dr. Miller excels at translating complex scientific concepts into clear, actionable insights. His ability to engage with healthcare professionals, research teams, and industry leaders ensures that critical medical knowledge is effectively shared and applied.